Institution statistics

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM - Netherlands 

Ranking results:

2012
Criterium:Position:
Overall Score:100-200
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2011
Criterium:Position:
Overall Score:100-200
Total Project Funding:44
Total Project Funding per Partner:92
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
Partner Constancy:61
Project Leadership Index:100-200
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:100-200
Total Project Funding:86
Total Project Funding per Partner:65
Total Number of Projects:92
Networking Rank (Reputation):99
Partner Constancy:300-400
Project Leadership Index:60
Diversity Index:600-700
2009
Criterium:Position:
Overall Score:100-200
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
Partner Constancy:400-500
Project Leadership Index:100-200
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:64
Total Project Funding:44
Total Project Funding per Partner:51
Total Number of Projects:52
Networking Rank (Reputation):66
Partner Constancy:77
Project Leadership Index:54
Diversity Index:700-800
2007
Criterium:Position:
Overall Score:100-200
Total Project Funding:62
Total Project Funding per Partner:63
Total Number of Projects:88
Networking Rank (Reputation):87
Partner Constancy:100-200
Project Leadership Index:100-200
Diversity Index:> 1000

European project participation (2000-01-01 - 2013-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Total funding / No of participants

Projects:
Leadership:

Total number of projects: 169
As coordinator: 27
As participant: 117
Sole participant: 25
Coordinator / Participant Ratio: 0.23*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2004 2.875.996 37.334.892 2.080.581 1 6
2005 14.039.822 17.952.544 2.072.430 3 2
2006 9.122.623 75.938.473 5.506.990 5 14
2007 157.063 28.704.041 2.419.343 1 7
2008 27.357.833 129.799.922 11.231.195 11 21
2009 17.249.948 52.168.664 5.171.543 3 11
2010 14.252.633 86.070.919 12.321.095 9 16
2011 22.878.975 144.671.296 10.823.718 7 15
2012 17.854.915 98.067.058 15.202.830 9 22
2013 4.522.100 22.929.118 4.323.007 3 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE32
UNIVERSITY COLLEGE LONDON23
KAROLINSKA INSTITUTE21
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE20
LEIDEN UNIVERSITY MEDICAL CENTER18
KATHOLIEKE UNIVERSITEIT LEUVEN17
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD17
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE16
KING'S COLLEGE LONDON13
STICHTING KATHOLIEKE UNIVERSITEIT13
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER13
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE12
CHARITE UNIVERSITAETSMEDIZIN BERLIN12
EUROPEAN MOLECULAR BIOLOGY LABORATORY12
UPPSALA UNIVERSITET12
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN11
UNIVERSITY OF COPENHAGEN11
UNIVERSITY OF NEWCASTLE UPON TYNE11
LUNDS UNIVERSITET10
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM9
ACADEMISCH ZIEKENHUIS GRONINGEN9
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT9
INSTITUT CURIE9
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV9
THE UNIVERSITY OF LIVERPOOL9
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III8
INSTITUT GUSTAVE ROUSSY8
INSTITUT PASTEUR8
THE UNIVERSITY OF EDINBURGH8
UNIVERSITAET ZUERICH8
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG8
WEIZMANN INSTITUTE OF SCIENCE8
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS7
ISTITUTO SUPERIORE DI SANITA7
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL7
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA7
UNIVERSITAET ULM7
UNIVERSITEIT ANTWERPEN7
UNIVERSITEIT GENT7
UNIVERSITY OF BIRMINGHAM7
UNIVERSITY OF YORK7
GENOME RESEARCH6
ISLENSK ERFDAGREINING EHF6
MEDICAL RESEARCH COUNCIL6
MILTENYI BIOTEC6
TECHNISCHE UNIVERSITAET DRESDEN6
UNIVERSITA DEGLI STUDI DI PADOVA6
UNIVERSITA DEGLI STUDI DI TORINO6
UNIVERSITE DE GENEVE6
UNIVERSITE VICTOR SEGALEN BORDEAUX II6
UNIVERSITY OF HELSINKI6
UNIVERSITY OF SOUTHAMPTON6
UNIVERSITY OF TAMPERE6
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
DANISH CANCER SOCIETY5
DANMARKS TEKNISKE UNIVERSITET5
DEUTSCHES KREBSFORSCHUNGSZENTRUM5
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR5
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS5
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL5
INSTITUTO DE SALUD CARLOS III5
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER5
KUNGLIGA TEKNISKA HOEGSKOLAN5
MEDIZINISCHE UNIVERSITAET INNSBRUCK5
NORWEGIAN INSTITUTE OF PUBLIC HEALTH5
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU5
ST GEORGE'S HOSPITAL MEDICAL SCHOOL5
THE HEBREW UNIVERSITY OF JERUSALEM5
THE UNIVERSITY OF NOTTINGHAM5
UNIVERSITA DEGLI STUDI DI MILANO5
UNIVERSITAETSKLINIKUM BONN5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
UNIVERSITAT POMPEU FABRA5
UNIVERSITY OF LEICESTER5
CANCER RESEARCH UK4
CONSIGLIO NAZIONALE DELLE RICERCHE4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
FUNDACIO IMIM4
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA4
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O4
MEDIZINISCHE UNIVERSITAET GRAZ4
PHARMO COOPERATIE UA4
SYDDANSK UNIVERSITET4
TERVEYDEN JA HYVINVOINNIN LAITOS4
THE QUEEN'S UNIVERSITY OF BELFAST4
THE UNIVERSITY OF MANCHESTER4
THE UNIVERSITY OF SHEFFIELD4
UNIVERSITA DEGLI STUDI DI SIENA4
UNIVERSITAET BASEL4
UNIVERSITAET ZU LUEBECK4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITE LIBRE DE BRUXELLES4
UNIVERSITEIT MAASTRICHT4
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK4
UNIVERSITY OF BRISTOL4
UNIVERSITY OF TURKU4
UNIVERSITY OF WALES CARDIFF4
VIB4
Constancy:

Total number of partners:1945

Partner loyalty:
Frequent Partner: (> 2 projects): 914
Rare Partner: 1031

Frequent / Rare Partner Ratio: 0.89

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES105
RTD HORIZONTAL TOPICS47
INDUSTRY AND TECHNOLOGY15
ENERGY2
SOCIAL AND ECONOMIC CONCERNS2

Project overview:

Start dateProjectacronymrolefundingpartners
2013-05-01Full biomechanical characterization of the coronary atherosclerotic plaque: biomechanics meets imaging BIOCCORAcoordinator1.877.0001
2013-04-01VPH Dementia Research Enabled by IT VPH-DARE@ITparticipant13.393.56520
2013-04-01Identification and functional validation of drugable targets/pathways for triple negative breast cancer TRIPLE-BCcoordinator2.495.1013
2013-03-01LED Cued Learning Technology LCLTcoordinator149.9991
2013-03-01Co-morbidity in relation to Aids COBRAparticipant5.998.75812
2013-01-01Initial Training Network for Neurogical disorders orchestrated by cytoKines NEUROKINEparticipant3.536.79512
2012-12-01New and more individualised population-based screening for cardiovascular disease; from a RCT including selfassessments, primary care and coronary artery calcification score to modelling risk-benefit ROBINSCAcoordinator3.298.9992
2012-12-01Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder MEUSIXparticipant5.995.0418
2012-12-01ARCAS: Analysis of the Route to Commercialisation of MVA based influenza vaccines ARCAScoordinator149.8401
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00017
2012-11-01Evolutionary Determinants of Influenza Virus Pathogenesis and Tissue Tropism INFLUENZA TROPISMcoordinator183.8051
2012-11-01THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia THALAMOSSparticipant5.020.00013
2012-11-01IMPROvED: IMproved Pregnancy Outcomes by Early Detection; personalized medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome. IMPROVEDparticipant5.995.39012
2012-10-01MARie CuRIe AGEing Network MARRIAGEparticipant3.955.36211
2012-10-01Rational molecular Assessments and Innovative Drug Selection RAIDSparticipant5.999.64216
2012-10-01Development of COMBInatorial BIOmarkers for subclinical atherosclerosis COMBI-BIOparticipant2.964.6956
2012-10-01Molecular technology for nuclear imaging and radionuclide therapy TRACENTREATparticipant2.124.6596
2012-10-01Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) DSD-LIFEparticipant2.999.95618
2012-10-01Novel Diagnostics and Biomarkers for Early Identification of Chronic Inflammatory Joint Diseases D-BOARDparticipant5.993.45911
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29411
2012-09-01Automated Next Generation Sequencing for Diagnostic Microbiology PATHSEEKparticipant5.887.0334
2012-09-01SERVICES ASSOCIATED TO DIGITALISED CONTENTS OF TISSUES IN BIOBANKS ACROSS EUROPE BIOPOOLparticipant1.966.0007
2012-07-01Multilingual Annotation of Named Entities and Terminology Resources Acquisition MANTRAparticipant1.799.8886
2012-06-01Advanced Immuno-neuro-endocrine Diagnostics in Psychiatry PSYCH-AIDcoordinator3.649.51410
2012-04-01The interplay among bone cells, matrices and systems INTERBONEparticipant233.1002
2012-04-01Cracking the Cerebellar Code CCCcoordinator2.499.6001
2012-03-01Immune regulation of NF-kappaB in Dendritic Cell subsets by the ubiquitin editing enzyme A20 A20 DC SUBSETScoordinator100.0001
2012-02-01Effective Communication in Outbreak Management: development of an evidence-based tool for Europe E-COM@EUcoordinator1.999.6079
2012-02-01Long-term effects of early nutrition on later health EARLYNUTRITIONparticipant8.962.77136
2012-01-01Developing methodologies to reduce inequalities in the determinants of health DEMETRIQcoordinator3.000.0009
2012-01-01Ovarian Cancer Therapy Innovative Models Prolong Survival OCTIPSparticipant2.999.30211
2012-01-01Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis REGENER-ARparticipant5.925.46110
2012-01-01Companion Animals multisectoriaL interprofessionaL and Interdisciplinary Strategic Think tank On zoonoses CALLISTOparticipant999.9989
2012-01-01Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform PARCIVALcoordinator2.973.5509
2012-01-01Reproductive Biology Early Research Training REPRO-TRAINparticipant3.649.8288
2012-01-01Building data bridges between biological and medical infrastructures in Europe BIOMEDBRIDGESparticipant10.494.99821
2012-01-01Stromal Cell- Immune Cell Interactions in Health and Disease STROMAparticipant4.296.18111
2011-12-01The genetic basis of meningococcal and other life threatening bacterial infections of childhood EUCLIDSparticipant11.988.64714
2011-11-01ANTIcipating the Global Onset of Novel Epidemics ANTIGONEcoordinator11.997.70914
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66442
2011-10-01Communication of European Health Research COMMHEREparticipant1.998.44110
2011-10-01Safety Evaluation of Adverse Reactions in Diabetes SAFEGUARDcoordinator2.997.19614
2011-10-01Cognitive and Cerebrovascular Effects Induced by Low Dose Ionising Radiation CEREBRADparticipant2.999.51711
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67042
2011-05-01Mechanisms and functions of microtubule plus end tracking proteins in mammalian cells: development of inhibitory strategies. MT-TIP INHIBITORScoordinator169.5351
2011-04-01Molecular mechanisms controlling X chromosome inactivation ACTIVATION OF XCIcoordinator1.500.0001
2011-04-01Economic Cycles, Employment and Health: Disentangling Causal Pathways in a Cross-National Study HEALTHCYCLEparticipant1.273.2802
2011-04-01Recombinational DNA repair analyzed by simultaneous scanning force and single molecule fluorescence microscopy: role of RAD54 in presynaptic and postsynaptic events DNAREPAIR AT 3DETAILcoordinator45.0001
2011-04-01Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugs PHARMACHILDparticipant2.973.9769
2011-02-01Promoting and Monitoring Biomedical Informatics in Europe INBIOMEDVISIONparticipant998.0007

overview shows latest 50 from 169 projects (2000-01-01 - 2013-12-31)

Alias institution names:
  • ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: